Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q2 2025 Earnings

14MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.57

-0.52

-0.46

-0.41

Details

Expected EPS

-0.5015

Actual EPS

-0.57

Surprise EPS

-0.07

Surprise Percent

+13.66%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.57 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.